Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

GENENTECH, INC.

Filed by TODD STRATEGY GROUP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 21, 2026
Income
$60,000.00
Expenses
Not reported
Filing UUID
94c2cf4d-9afa-413f-a68e-bc3c3672c743
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

Prescription drug payment reform. Supply chain. Strategic National Stockpile.

MMM · Medicare/Medicaid

Medicare and Medicaid payment issues. 340B. Implementation of Inflation Reduction Act of 2022.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.